Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
10/2007
10/10/2007EP1841741A1 Piperidine derivatives as prodrugs of potassium channel inhibitors
10/10/2007EP1841737A1 N-(heteroaryl)-1h-indole-2-carboxamide derivatives and their use as vanilloid trpv1 receptor ligands
10/10/2007EP1841735A1 Indoles useful in the treatment of inflammation
10/10/2007EP1581515B1 Triazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1
10/10/2007EP1442019B1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
10/10/2007EP1399163B1 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (bvdv) infection and hepatitis c virus (hcv) infection
10/10/2007EP1379525B1 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/10/2007EP1300159B1 Remedies for cancer
10/10/2007EP1232150B1 Urea derivatives as anti-inflammatory agents
10/10/2007EP1142879B1 Imidazole compounds and medicinal use thereof
10/10/2007EP0944633B1 Substituted phenylketoenols and their use as pesticides and herbicides
10/10/2007CN101052639A Benzimidazole derivatives, composition containing thereof, its preparation method and application
10/10/2007CN101052638A 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists
10/10/2007CN101052637A Benzimidazole derivatives and their application as cannabinoid receptor ligand i
10/10/2007CN101052627A Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
10/10/2007CN101052621A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
10/10/2007CN101052620A Benzamide compound
10/10/2007CN100341870C Glycosidase inhibitors and preparation thereof
10/10/2007CN100341854C Preparation of N1-(2'-pyridyl)-1,2-propanediamine sulfamic acid and its use in the synthesis of biologically active piperazines
10/09/2007US7279582 For example (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl)amino-3-hydroxy-5-(2S-(1-tetrahydro-pyrimid-2-onyl)-3-methyl butanoyl)amino-1,6-diphenylhexane; HIV therapy
10/09/2007US7279581 Diazotization of 4-(1,2,4-triazol-1-ylmethyl)phenylamine hydrochloride, reduction and acidification, reaction with hydrazine hydrochloride and alpha -keto- delta -valerolactone, Fischer indole reaction, hydrolysis, transesterification, conversion of hydroxyl group to dimethylamino group
10/09/2007US7279574 Heat conductivity, it is also useful as an insulating material requiring high heat releasability such as a printed circuit substrate
10/09/2007US7279498 Substituted aryl amides as IP antagonists
10/09/2007US7279497 Benzopyran derivatives substituted with secondary amines including imidazole, their preparation and pharmaceutical compositions containing them
10/09/2007US7279490 Ophthalmic compositions for treating ocular hypertension
10/09/2007US7279489 Compounds and methods for modulation of estrogen receptors
10/09/2007US7279488 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions
10/09/2007US7279481 1-(3-{2-[4-(2-Methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-2-imidazolidinone; therapy of depression or anxiety
10/09/2007US7279477 Cardiovascular disease, diabetes, acidosis, cancer, obesity; such as 1-butyl-3,3-dimethyl-1-(4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethyl -ethyl)-phenyl)-thiourea
10/09/2007US7279476 Anticancer agents, antiinflamamtory agents, restenosis, cardiovascular disorders; insertable device
10/09/2007US7279475 Cytokine inhibitors, useful for treating diseases and pathological conditions involving inflammation such as chronic inflammatory disease; for example, 1-(2-methoxy-5-trifluoromethyl-phenyl)-3-{4-[6-methyl-2-(2-morpholin-4-yl-ethyl)-pyrimidin-4-yloxy]-naphthalen-1-yl}-urea
10/09/2007US7279472 cathepsins inhibitors such as N-(4-Cyano-methyl-piperidin-4-yl)-3-cyclohexyl-2-(3-oxo-3H-isoindol-1-ylamino)-propionamide, used for treating autoimmune diseases such as arthritis, multiple sclerosis, asthma and osteoporosis
10/09/2007US7279471 Butane-1,4-diones 1-substituted by a phenyltriazonylpiperidinyl- or benzo-1,3-diazepinonylpiperidinyl- group, e.g., (1) 1-(1,4'-bipiperidinyl-1'-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5,-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butane-1,4-dione; treating headaches, diabetes
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007US7279469 Diaminotriazoles useful as inhibitors of protein kinases
10/09/2007US7279314 Chemical substance having morphogenetic and growth-accelerating activities
10/09/2007US7279264 fluorescein dyes that exhibit a first color when in the crystal structured form and a second color when in the liquid, amorphous form, for use in thermal printing
10/04/2007WO2007111323A1 Ureide derivative and use thereof for medical purposes
10/04/2007WO2007111212A1 Triazolone derivative
10/04/2007WO2007110868A2 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/04/2007WO2007110667A1 Piperidines and related compounds for the treatment of dementia
10/04/2007WO2007110418A2 Substituted 5-hetaryl-4-aminopyrimidines
10/04/2007WO2007110374A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/04/2007WO2007110344A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007WO2007092846A3 2-AMINO-3,4-DIHYDRO-QUINOLINE DERIVATIVES USEFUL AS INHIBITORS OF β-SECRETASE (BACE)
10/04/2007WO2007085556A3 Use of 4-imidazole derivatives for cns disorders
10/04/2007WO2007072201A3 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
10/04/2007WO2007066181A3 Methods of preparing a vegf-r inhibitor
10/04/2007US20070232663 Small molecule insulin mimetics absent quinones
10/04/2007US20070232657 Novel compounds
10/04/2007US20070232639 Camptothecin Derivatives Conjugated in Position 20 with Integrin Antagonists
10/04/2007US20070232620 N-3-chlorobenzyl-3-amino-1H-indazole-5-carboxamide; 3-aminoindazoles; glucocorticoid-depedent kinase (SGK) inhibitors; SGK-induced diseases; diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, fibrosis; inflammatory agents
10/04/2007US20070232619 Piperazine Derivatives of Dialkyl Oxindoles
10/04/2007US20070232613 4-(1-Piperazinyl)-2(1H)-quinolone and 4-(1-piperazinyl)quinoline derivatives, e.g., 3-nitro- or 3-alkoxycarbonyl-1-methyl-4-[4-thiophene-2-carbonyl)-piperazine-1-yl]-1H-quinolin-2-one; antitumor and angiogenesis inhibitor, antiinflammatory, antidiabetic agent, autoimmune disorder
10/04/2007US20070232605 Inhibitors of soluble adenylate cyclase
10/04/2007US20070232600 Anti-migraine treatments
10/04/2007US20070232583 Central nervous system disorders; metabotropic glutamate receptors (mGluR); 2-(4-Pyridin-3-yl-imidazol-1-yl)-4-trifluoromethyl-6-(4-trifluoromethyl-phenyl)-pyrimidine
10/04/2007US20070231318 Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
10/04/2007DE102006015470A1 Substituierte Enaminocarbonylverbindungen Substituted enaminocarbonyl
10/04/2007DE102006015468A1 Substituierte Enaminocarbonylverbindungen Substituted enaminocarbonyl
10/04/2007DE102006015467A1 Substituierte Enaminocarbonylverbindungen Substituted enaminocarbonyl
10/04/2007CA2680789A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
10/04/2007CA2647603A1 Ureide derivative and use thereof for medical purposes
10/04/2007CA2647423A1 Triazolone derivative
10/04/2007CA2647290A1 Piperidines and related compounds for the treatment of dementia
10/04/2007CA2647252A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
10/04/2007CA2646952A1 Pyridyl- and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives as kinase inhibitors
10/04/2007CA2645779A1 Substituted 5-hetaryl-4-aminopyrimidines
10/03/2007EP1840213A1 Target physiological function inactivator using photosensitizer-labeled fluorescent protein
10/03/2007EP1840128A1 Crystal of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1- methylpyridin-2(1h)-one and process for producing the same
10/03/2007EP1840125A2 Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics
10/03/2007EP1840122A1 Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
10/03/2007EP1840121A1 Glycine derivative and use thereof
10/03/2007EP1839659A2 Chemicals compounds
10/03/2007EP1838800A1 Compositions, redox couples and uses thereof
10/03/2007EP1838704A1 Selected benzofuran derivatives
10/03/2007EP1838694A1 5-thioxo-1,5-dihydro-2h-pyrrol-2-one derivatives as liver x receptor modulators
10/03/2007EP1838672A1 4-piperidinol tertiary amines as histamine 3 receptor inhibitors for the treatment of obesity and other cns disorders
10/03/2007EP1838296A2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases
10/03/2007EP1599468B1 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
10/03/2007EP1599167B1 Benzimidazole and imidazopyridine derivatives having affinity for the melanocortin receptors and use thereof as a medicament
10/03/2007EP1529044B1 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
10/03/2007EP1456180B1 3-(2,4)dihydroxyphenyl-4-phenylpyrazoles and their medical use
10/03/2007EP1362855B1 Beta-lactam compounds, process for repoducing the same and serum cholesterol-lowering agents containing the same
10/03/2007EP1304324B1 Serotonin reuptake inhibitors
10/03/2007EP1294378B1 Thrombopoietin mimetics
10/03/2007EP1173421B1 Indole derivatives as anti-inflammation agents
10/03/2007CN101048465A Polymeric luminescent material composition and polymeric light-emitting device
10/03/2007CN101048392A Novel use
10/03/2007CN101048388A Quinazolinone derivatives and their use as B-Raf inhibitors
10/03/2007CN101045727A Inhibitors of tyrosine kinases
10/03/2007CN100340554C Halogen substituted tetracyclic tetrahydrofuran derivatives
10/02/2007US7276612 For hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides
10/02/2007US7276608 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders
10/02/2007US7276606 Phenantridine analogues and uses thereof
10/02/2007US7276603 serotonin receptor antagonists such as 8-{4-[2-(1-benzofuran-3-yl)ethyl]-1-piperazinyl}-6-fluoroquinoline, used for treatment and/or prevention of depression, anxiety and cognitive deficits arising from Alzheimer's disease, neurodegenerative disorders, schizophrenia and prostate cancer
10/02/2007US7276601 Method and preparing fused oxazinones
10/02/2007US7276592 Nucleotide analogs with six-membered rings
10/02/2007US7276531 G-lactam derivatives as prostaglandin agonists
10/02/2007US7276524 Compounds as antumor agents or immunosuppressants
1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 694